Immunotherapy aims to modulate the immune system to prevent the destruction of insulin-producing cells in the pancreas, which is a hallmark of T1D. Several studies have investigated the use of Antigen-specific immunotherapy, Immune checkpoint inhibitors, Mesenchymal stem cells (MSCs), etc., to delay or prevent the onset of T1D. Join us in this session to learn more about the recent updates on immunotherapy to delay Type 1 diabetes.
Speaker
Dr. Anirban Sinha
Associate Professor Endocrinology Medical College, Kolkata